Prolongation of duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) by ineffective doses of clofibrate in diabetes insipidus.
D002994:Clofibrate / Q000627:therapeutic use*; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use*; D003919:Diabetes Insipidus / Q000188:drug therapy*; D006801:Humans; D014667:Vasopressins / Q000031:analogs & derivatives*
D014667:Vasopressins; D003894:Deamino Arginine Vasopressin; D002994:Clofibrate